Desloratadine Suppliers & Bulk Manufacturers
Available Forms: Tablets & Syrup
Available Strengths: Tab: 5 mg; syrup: 0.5 mg/mL or 2.5 mg/5 mL
Reference Brands: Clarinex® (US); Aerius®, Desloratadine Teva(EU)
Category:
Allergy Medication
Desloratadine 5 mg tablets provide 24-hour relief from allergic rhinitis and chronic hives with minimal sedation. Trusted brands include Clarinex® and Aerius®, widely used in the EU and US.
Desloratadine is available in Tablets & Syrup
and strengths such as Tab: 5 mg; syrup: 0.5 mg/mL or 2.5 mg/5 mL.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Desloratadine is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Desloratadine can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Desloratadine Tablets (5 mg) are fast-acting, long-lasting antihistamines used for the treatment of seasonal allergic rhinitis, chronic hives, and other allergy-related symptoms. As a second-generation, non-sedating antihistamine, Desloratadine offers 24-hour relief with minimal side effects. Widely prescribed in both the EU and US, it is available under trusted brands like Clarinex®, Aerius®, and multiple generics. Manufactured in GMP-certified facilities, Desloratadine is ideal for B2B supply, bulk procurement, and private labeling in regulated pharmaceutical markets.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing